| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 7.58e-07 | 337 | 45 | 8 | GO:0001664 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 2.38e-05 | 25 | 45 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.77e-04 | 372 | 45 | 6 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.55e-04 | 398 | 45 | 6 | GO:0061659 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 2.70e-04 | 11 | 45 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 3.81e-04 | 13 | 45 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 6.37e-04 | 473 | 45 | 6 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 9.62e-04 | 512 | 45 | 6 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.17e-03 | 532 | 45 | 6 | GO:0016755 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 1.33e-03 | 24 | 45 | 2 | GO:0031690 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.62e-03 | 775 | 45 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.36e-03 | 32 | 45 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.38e-03 | 417 | 45 | 5 | GO:0061629 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 6.21e-05 | 35 | 46 | 3 | GO:0005834 | |
| GeneOntologyCellularComponent | GTPase complex | 1.00e-04 | 41 | 46 | 3 | GO:1905360 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.47e-04 | 230 | 46 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.47e-04 | 230 | 46 | 5 | GO:0019898 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.33e-04 | 137 | 46 | 4 | GO:0019897 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 2.55e-04 | 56 | 46 | 3 | GO:0031234 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 6.31e-04 | 17 | 46 | 2 | GO:0090443 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 7.09e-04 | 18 | 46 | 2 | GO:0000159 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 7.25e-04 | 185 | 46 | 4 | GO:0009898 | |
| MousePheno | abnormal fasting circulating glucose level | 2.16e-05 | 474 | 36 | 8 | MP:0013277 | |
| Domain | HECT | 4.95e-07 | 27 | 45 | 4 | PF00632 | |
| Domain | HECTc | 4.95e-07 | 27 | 45 | 4 | SM00119 | |
| Domain | HECT_dom | 4.95e-07 | 27 | 45 | 4 | IPR000569 | |
| Domain | HECT | 4.95e-07 | 27 | 45 | 4 | PS50237 | |
| Domain | WW | 4.86e-06 | 47 | 45 | 4 | PF00397 | |
| Domain | WW | 5.29e-06 | 48 | 45 | 4 | SM00456 | |
| Domain | E3_ub_ligase_SMURF1 | 5.68e-06 | 2 | 45 | 2 | IPR024928 | |
| Domain | WW_DOMAIN_2 | 6.76e-06 | 51 | 45 | 4 | PS50020 | |
| Domain | WW_DOMAIN_1 | 6.76e-06 | 51 | 45 | 4 | PS01159 | |
| Domain | G-alpha | 7.16e-06 | 16 | 45 | 3 | PF00503 | |
| Domain | GproteinA_insert | 7.16e-06 | 16 | 45 | 3 | IPR011025 | |
| Domain | - | 7.16e-06 | 16 | 45 | 3 | 1.10.400.10 | |
| Domain | G_alpha | 7.16e-06 | 16 | 45 | 3 | SM00275 | |
| Domain | WW_dom | 7.31e-06 | 52 | 45 | 4 | IPR001202 | |
| Domain | Gprotein_alpha_su | 8.68e-06 | 17 | 45 | 3 | IPR001019 | |
| Domain | Gprotein_alpha_I | 1.57e-04 | 8 | 45 | 2 | IPR001408 | |
| Domain | TBC | 2.23e-04 | 49 | 45 | 3 | SM00164 | |
| Domain | C2 | 2.76e-04 | 131 | 45 | 4 | PF00168 | |
| Domain | RabGAP-TBC | 2.81e-04 | 53 | 45 | 3 | PF00566 | |
| Domain | TBC_RABGAP | 3.14e-04 | 55 | 45 | 3 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 3.14e-04 | 55 | 45 | 3 | IPR000195 | |
| Domain | C2 | 3.27e-04 | 137 | 45 | 4 | SM00239 | |
| Domain | C2 | 3.75e-04 | 142 | 45 | 4 | PS50004 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 4.35e-04 | 13 | 45 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 4.35e-04 | 13 | 45 | 2 | PS00125 | |
| Domain | PP2Ac | 4.35e-04 | 13 | 45 | 2 | SM00156 | |
| Domain | - | 4.38e-04 | 148 | 45 | 4 | 2.60.40.150 | |
| Domain | C2_dom | 6.45e-04 | 164 | 45 | 4 | IPR000008 | |
| Domain | ARM-type_fold | 1.29e-03 | 339 | 45 | 5 | IPR016024 | |
| Domain | Calcineurin-like_PHP_ApaH | 2.06e-03 | 28 | 45 | 2 | IPR004843 | |
| Domain | Metallophos | 2.06e-03 | 28 | 45 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 2.37e-03 | 30 | 45 | 2 | IPR029052 | |
| Domain | - | 2.37e-03 | 30 | 45 | 2 | 3.60.21.10 | |
| Domain | HEAT | 8.61e-03 | 58 | 45 | 2 | IPR000357 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 6.98e-07 | 71 | 34 | 5 | MM14491 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.28e-06 | 90 | 34 | 5 | M6467 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 4.58e-06 | 14 | 34 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 4.58e-06 | 14 | 34 | 3 | M750 | |
| Pathway | PID_TGFBR_PATHWAY | 8.19e-06 | 54 | 34 | 4 | M286 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 2.31e-05 | 70 | 34 | 4 | M8232 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 5.85e-05 | 289 | 34 | 6 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 9.25e-05 | 314 | 34 | 6 | M600 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.10e-04 | 39 | 34 | 3 | MM14496 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.17e-04 | 646 | 34 | 8 | MM14962 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.18e-04 | 7 | 34 | 2 | M26992 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.48e-04 | 43 | 34 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.59e-04 | 44 | 34 | 3 | MM15709 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 2.01e-04 | 9 | 34 | 2 | M26930 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 2.01e-04 | 9 | 34 | 2 | MM14535 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 2.08e-04 | 702 | 34 | 8 | M746 | |
| Pathway | REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION | 2.51e-04 | 10 | 34 | 2 | M27176 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 2.51e-04 | 10 | 34 | 2 | MM14509 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.74e-04 | 132 | 34 | 4 | M11355 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.92e-04 | 54 | 34 | 3 | M26911 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 2.99e-04 | 135 | 34 | 4 | M15247 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 3.67e-04 | 12 | 34 | 2 | M27950 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.99e-04 | 60 | 34 | 3 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.99e-04 | 60 | 34 | 3 | MM15708 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 4.33e-04 | 13 | 34 | 2 | M1015 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 4.33e-04 | 13 | 34 | 2 | M39589 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 4.33e-04 | 13 | 34 | 2 | MM14811 | |
| Pathway | WP_DOPAMINE_METABOLISM | 4.33e-04 | 13 | 34 | 2 | M39622 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 4.33e-04 | 13 | 34 | 2 | M8410 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 5.81e-04 | 15 | 34 | 2 | M27407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 6.63e-04 | 16 | 34 | 2 | M47870 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 6.63e-04 | 16 | 34 | 2 | MM14699 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 6.63e-04 | 16 | 34 | 2 | MM14541 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 6.63e-04 | 16 | 34 | 2 | M514 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 7.51e-04 | 17 | 34 | 2 | MM15096 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 7.51e-04 | 17 | 34 | 2 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 7.51e-04 | 17 | 34 | 2 | M919 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 8.43e-04 | 18 | 34 | 2 | MM14759 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 9.41e-04 | 19 | 34 | 2 | M47525 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 9.41e-04 | 19 | 34 | 2 | MM14780 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 1.04e-03 | 20 | 34 | 2 | M47876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 1.15e-03 | 21 | 34 | 2 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 1.15e-03 | 21 | 34 | 2 | MM14996 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.27e-03 | 22 | 34 | 2 | MM15016 | |
| Pathway | REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION | 1.27e-03 | 22 | 34 | 2 | M6768 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.27e-03 | 22 | 34 | 2 | M841 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 1.27e-03 | 22 | 34 | 2 | M47919 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.27e-03 | 22 | 34 | 2 | M13408 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.51e-03 | 24 | 34 | 2 | M751 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.64e-03 | 25 | 34 | 2 | MM15379 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 1.64e-03 | 25 | 34 | 2 | M808 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | 1.72e-03 | 99 | 34 | 3 | M46448 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.77e-03 | 100 | 34 | 3 | MM14561 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.82e-03 | 101 | 34 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.82e-03 | 101 | 34 | 3 | M39387 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.91e-03 | 27 | 34 | 2 | MM14779 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 2.05e-03 | 28 | 34 | 2 | MM15132 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 2.20e-03 | 29 | 34 | 2 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 2.20e-03 | 29 | 34 | 2 | MM15253 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.20e-03 | 108 | 34 | 3 | M17034 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.38e-03 | 111 | 34 | 3 | M27673 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.51e-03 | 31 | 34 | 2 | M27400 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 2.51e-03 | 31 | 34 | 2 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 2.51e-03 | 31 | 34 | 2 | MM15254 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.51e-03 | 31 | 34 | 2 | MM15154 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 2.51e-03 | 31 | 34 | 2 | M15195 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.76e-03 | 117 | 34 | 3 | MM15387 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING | 2.84e-03 | 33 | 34 | 2 | M27526 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 2.84e-03 | 33 | 34 | 2 | MM15252 | |
| Pathway | WP_ENDOTHELIN_PATHWAYS | 2.84e-03 | 33 | 34 | 2 | M39651 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 2.84e-03 | 33 | 34 | 2 | MM15020 | |
| Pathway | WP_PURINERGIC_SIGNALING | 2.84e-03 | 33 | 34 | 2 | M39855 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 2.84e-03 | 33 | 34 | 2 | M9379 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 2.84e-03 | 33 | 34 | 2 | MM14523 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 3.02e-03 | 34 | 34 | 2 | M27405 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 3.02e-03 | 34 | 34 | 2 | M27527 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.02e-03 | 34 | 34 | 2 | M27556 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 3.02e-03 | 34 | 34 | 2 | MM15985 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 3.02e-03 | 34 | 34 | 2 | M42555 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.20e-03 | 35 | 34 | 2 | MM15271 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 3.38e-03 | 36 | 34 | 2 | MM15339 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.48e-03 | 127 | 34 | 3 | M27181 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 3.57e-03 | 37 | 34 | 2 | M27641 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.64e-03 | 129 | 34 | 3 | MM14894 | |
| Pathway | PID_ERBB4_PATHWAY | 3.76e-03 | 38 | 34 | 2 | M13 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 3.96e-03 | 39 | 34 | 2 | MM15257 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.96e-03 | 39 | 34 | 2 | MM14604 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 4.15e-03 | 649 | 34 | 6 | MM15690 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 4.16e-03 | 40 | 34 | 2 | M39595 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 4.16e-03 | 40 | 34 | 2 | M27532 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 4.16e-03 | 40 | 34 | 2 | MM15258 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 4.16e-03 | 40 | 34 | 2 | M41 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 4.37e-03 | 41 | 34 | 2 | M27533 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 4.58e-03 | 42 | 34 | 2 | MM15274 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.58e-03 | 140 | 34 | 3 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.67e-03 | 141 | 34 | 3 | MM15266 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 4.79e-03 | 43 | 34 | 2 | M29837 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 4.79e-03 | 43 | 34 | 2 | M27560 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.95e-03 | 144 | 34 | 3 | MM14501 | |
| Pathway | REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1 | 5.01e-03 | 44 | 34 | 2 | MM15377 | |
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 4.01e-11 | 6 | 46 | 4 | 9647693 | |
| Pubmed | Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases. | 2.17e-09 | 3 | 46 | 3 | 12450395 | |
| Pubmed | K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling. | 2.65e-09 | 14 | 46 | 4 | 31015455 | |
| Pubmed | Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations. | 4.82e-09 | 16 | 46 | 4 | 25723849 | |
| Pubmed | Disinhibition of the HECT E3 ubiquitin ligase WWP2 by polymerized Dishevelled. | 8.65e-09 | 4 | 46 | 3 | 26701932 | |
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 28475870 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 3.92e-08 | 26 | 46 | 4 | 26949039 | |
| Pubmed | Transmembrane adaptor protein WBP1L regulates CXCR4 signalling and murine haematopoiesis. | 7.55e-08 | 7 | 46 | 3 | 31845480 | |
| Pubmed | A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover. | 1.21e-07 | 8 | 46 | 3 | 19307600 | |
| Pubmed | 1.90e-07 | 97 | 46 | 5 | 25071155 | ||
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 25092867 | ||
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 17996703 | ||
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 21191027 | ||
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 22773947 | ||
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | 3.55e-07 | 11 | 46 | 3 | 16863688 | |
| Pubmed | Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein. | 3.55e-07 | 11 | 46 | 3 | 25963657 | |
| Pubmed | 7.80e-07 | 14 | 46 | 3 | 26147758 | ||
| Pubmed | 9.74e-07 | 15 | 46 | 3 | 23236378 | ||
| Pubmed | 1.45e-06 | 17 | 46 | 3 | 28292929 | ||
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 1.71e-06 | 2 | 46 | 2 | 2837763 | |
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 1.71e-06 | 2 | 46 | 2 | 1846293 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 1.71e-06 | 2 | 46 | 2 | 2555176 | |
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 1.71e-06 | 2 | 46 | 2 | 27096707 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10543450 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11751260 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11113010 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 31965758 | ||
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 1.71e-06 | 2 | 46 | 2 | 34902541 | |
| Pubmed | 2.07e-06 | 19 | 46 | 3 | 21572392 | ||
| Pubmed | 2.83e-06 | 21 | 46 | 3 | 37005481 | ||
| Pubmed | ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation. | 2.83e-06 | 21 | 46 | 3 | 29416926 | |
| Pubmed | USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. | 3.28e-06 | 22 | 46 | 3 | 24850914 | |
| Pubmed | 4.05e-06 | 963 | 46 | 9 | 28671696 | ||
| Pubmed | 4.88e-06 | 25 | 46 | 3 | 23873930 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 7510677 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 29925997 | ||
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 5.13e-06 | 3 | 46 | 2 | 8206937 | |
| Pubmed | Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner. | 5.13e-06 | 3 | 46 | 2 | 19997087 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 10441131 | ||
| Pubmed | Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. | 5.13e-06 | 3 | 46 | 2 | 23341017 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 8383590 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 15252037 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 5.99e-06 | 195 | 46 | 5 | 17110338 | |
| Pubmed | Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. | 1.03e-05 | 4 | 46 | 2 | 21998041 | |
| Pubmed | Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. | 1.03e-05 | 4 | 46 | 2 | 9770493 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 27466427 | ||
| Pubmed | Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. | 1.03e-05 | 4 | 46 | 2 | 7616230 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 9920888 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 11371618 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 19580544 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 21454489 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 20522958 | ||
| Pubmed | The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. | 1.03e-05 | 4 | 46 | 2 | 14633983 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.36e-05 | 231 | 46 | 5 | 36597993 | |
| Pubmed | 1.37e-05 | 604 | 46 | 7 | 38803224 | ||
| Pubmed | 1.56e-05 | 407 | 46 | 6 | 12693553 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 19366705 | ||
| Pubmed | HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. | 1.71e-05 | 5 | 46 | 2 | 9009195 | |
| Pubmed | Protein phosphatase 2A interacts with and directly dephosphorylates RelA. | 1.71e-05 | 5 | 46 | 2 | 11591705 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 10640627 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 10903445 | ||
| Pubmed | Inhibition of HECT E3 ligases as potential therapy for COVID-19. | 1.71e-05 | 5 | 46 | 2 | 33762578 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 18596935 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 30392800 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.73e-05 | 1155 | 46 | 9 | 20360068 | |
| Pubmed | 2.40e-05 | 42 | 46 | 3 | 27578003 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 15252135 | ||
| Pubmed | ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. | 2.56e-05 | 6 | 46 | 2 | 37040401 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 10781942 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 25078664 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 37156795 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 20100830 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 29735529 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 9647778 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 11748237 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 15147202 | ||
| Pubmed | STRIPAK components determine mode of cancer cell migration and metastasis. | 2.56e-05 | 6 | 46 | 2 | 25531779 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 10698523 | ||
| Pubmed | Protein phosphatase 2A and separase form a complex regulated by separase autocleavage. | 3.58e-05 | 7 | 46 | 2 | 17604273 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 11046148 | ||
| Pubmed | Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. | 3.58e-05 | 7 | 46 | 2 | 23644597 | |
| Pubmed | The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development. | 3.58e-05 | 7 | 46 | 2 | 25546391 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 34860335 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 11526121 | ||
| Pubmed | X-linked microtubule-associated protein, Mid1, regulates axon development. | 3.58e-05 | 7 | 46 | 2 | 24194544 | |
| Pubmed | Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases. | 4.77e-05 | 8 | 46 | 2 | 31578285 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 1330687 | ||
| Pubmed | Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. | 4.77e-05 | 8 | 46 | 2 | 11007961 | |
| Pubmed | Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. | 4.77e-05 | 8 | 46 | 2 | 12912990 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 16262633 | ||
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 35768646 | ||
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 12370081 | ||
| Pubmed | The Nedd4-like protein KIAA0439 is a potential regulator of the epithelial sodium channel. | 4.77e-05 | 8 | 46 | 2 | 11244092 | |
| Pubmed | Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. | 4.77e-05 | 8 | 46 | 2 | 17719543 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 23462102 | ||
| Pubmed | 5.41e-05 | 55 | 46 | 3 | 31985874 | ||
| Pubmed | 5.41e-05 | 55 | 46 | 3 | 18448421 | ||
| Pubmed | 5.91e-05 | 159 | 46 | 4 | 31332168 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 18432318 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 12885400 | ||
| Interaction | FBXL15 interactions | 5.41e-07 | 29 | 46 | 4 | int:FBXL15 | |
| Interaction | WBP1L interactions | 2.41e-06 | 12 | 46 | 3 | int:WBP1L | |
| Interaction | ARRDC2 interactions | 6.91e-06 | 54 | 46 | 4 | int:ARRDC2 | |
| Interaction | TMEM255A interactions | 7.40e-06 | 17 | 46 | 3 | int:TMEM255A | |
| Interaction | UBE2L3 interactions | 8.10e-06 | 211 | 46 | 6 | int:UBE2L3 | |
| Interaction | BRAF interactions | 8.33e-06 | 212 | 46 | 6 | int:BRAF | |
| Interaction | URI1 interactions | 1.82e-05 | 143 | 46 | 5 | int:URI1 | |
| Interaction | POLR2A interactions | 2.55e-05 | 536 | 46 | 8 | int:POLR2A | |
| Interaction | ATN1 interactions | 6.56e-05 | 187 | 46 | 5 | int:ATN1 | |
| Interaction | MIR19A interactions | 7.94e-05 | 100 | 46 | 4 | int:MIR19A | |
| Interaction | UBE2D2 interactions | 8.11e-05 | 318 | 46 | 6 | int:UBE2D2 | |
| Interaction | SEPTIN4 interactions | 8.88e-05 | 38 | 46 | 3 | int:SEPTIN4 | |
| Interaction | MIR19B1 interactions | 9.24e-05 | 104 | 46 | 4 | int:MIR19B1 | |
| Interaction | PRRG4 interactions | 9.60e-05 | 39 | 46 | 3 | int:PRRG4 | |
| Interaction | LDLRAD3 interactions | 1.06e-04 | 7 | 46 | 2 | int:LDLRAD3 | |
| Interaction | WBP1 interactions | 1.20e-04 | 42 | 46 | 3 | int:WBP1 | |
| Interaction | ARRDC3 interactions | 1.53e-04 | 224 | 46 | 5 | int:ARRDC3 | |
| Interaction | NLRP1 interactions | 1.68e-04 | 47 | 46 | 3 | int:NLRP1 | |
| Interaction | SMAD7 interactions | 2.00e-04 | 127 | 46 | 4 | int:SMAD7 | |
| Interaction | UBE2E3 interactions | 2.32e-04 | 132 | 46 | 4 | int:UBE2E3 | |
| Interaction | ILDR1 interactions | 2.77e-04 | 11 | 46 | 2 | int:ILDR1 | |
| Interaction | SMAD6 interactions | 2.83e-04 | 56 | 46 | 3 | int:SMAD6 | |
| Interaction | NDFIP2 interactions | 2.83e-04 | 56 | 46 | 3 | int:NDFIP2 | |
| Interaction | CILK1 interactions | 3.14e-04 | 58 | 46 | 3 | int:CILK1 | |
| Interaction | LDLRAD4 interactions | 3.31e-04 | 59 | 46 | 3 | int:LDLRAD4 | |
| Interaction | PRR14L interactions | 3.31e-04 | 59 | 46 | 3 | int:PRR14L | |
| Interaction | TOP3B interactions | CSDE1 NSD1 CPSF1 PPP2CB RIPOR1 GNAI1 TRIO DNAJA1 LYST WWP1 A4GALT | 3.70e-04 | 1470 | 46 | 11 | int:TOP3B |
| Interaction | SSTR2 interactions | 3.91e-04 | 13 | 46 | 2 | int:SSTR2 | |
| Interaction | STRN interactions | 4.17e-04 | 154 | 46 | 4 | int:STRN | |
| Interaction | SCNN1A interactions | 4.21e-04 | 64 | 46 | 3 | int:SCNN1A | |
| Interaction | DVL3 interactions | 4.30e-04 | 280 | 46 | 5 | int:DVL3 | |
| Interaction | UBE2D3 interactions | 4.51e-04 | 283 | 46 | 5 | int:UBE2D3 | |
| Interaction | PPP2R2C interactions | 4.81e-04 | 67 | 46 | 3 | int:PPP2R2C | |
| Interaction | LAPTM5 interactions | 4.81e-04 | 67 | 46 | 3 | int:LAPTM5 | |
| Interaction | STRIP2 interactions | 5.03e-04 | 68 | 46 | 3 | int:STRIP2 | |
| Interaction | ARRDC1 interactions | 5.03e-04 | 68 | 46 | 3 | int:ARRDC1 | |
| Interaction | GNB5 interactions | 5.03e-04 | 68 | 46 | 3 | int:GNB5 | |
| Cytoband | 7q21 | 7.61e-05 | 13 | 46 | 2 | 7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 4.59e-04 | 149 | 46 | 3 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 7.70e-04 | 178 | 46 | 3 | chr7q21 | |
| Cytoband | 17q12 | 4.48e-03 | 99 | 46 | 2 | 17q12 | |
| Cytoband | 16q22.1 | 5.50e-03 | 110 | 46 | 2 | 16q22.1 | |
| GeneFamily | C2 and WW domain containing | 1.49e-05 | 4 | 29 | 2 | 838 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.92e-04 | 13 | 29 | 2 | 693 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 4.64e-04 | 20 | 29 | 2 | 1371 | |
| GeneFamily | PHD finger proteins | 9.12e-03 | 90 | 29 | 2 | 88 | |
| Coexpression | IBRAHIM_NRF1_UP | 8.06e-06 | 420 | 46 | 7 | M42509 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 2.15e-05 | 680 | 46 | 8 | M41089 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 2.55e-05 | 199 | 46 | 5 | M3314 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 2.62e-05 | 200 | 46 | 5 | M8312 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 88 | 46 | 4 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 168 | 46 | 4 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 168 | 46 | 4 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 168 | 46 | 4 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 5.78e-05 | 8 | 43 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 measurement | 5.78e-05 | 8 | 43 | 2 | EFO_0802739 | |
| Disease | Intellectual Disability | 4.67e-04 | 447 | 43 | 5 | C3714756 | |
| Disease | Epileptic encephalopathy | 8.79e-04 | 30 | 43 | 2 | C0543888 | |
| Disease | Global developmental delay | 9.68e-04 | 133 | 43 | 3 | C0557874 | |
| Disease | Anxiety Disorders | 1.89e-03 | 44 | 43 | 2 | C0003469 | |
| Disease | Anxiety neurosis (finding) | 1.89e-03 | 44 | 43 | 2 | C1279420 | |
| Disease | Anxiety States, Neurotic | 1.89e-03 | 44 | 43 | 2 | C0376280 | |
| Disease | venous thromboembolism | 4.45e-03 | 460 | 43 | 4 | EFO_0004286 | |
| Disease | nicotine dependence | 5.81e-03 | 78 | 43 | 2 | EFO_0003768 | |
| Disease | Autistic Disorder | 6.50e-03 | 261 | 43 | 3 | C0004352 | |
| Disease | feeling nervous measurement | 7.17e-03 | 87 | 43 | 2 | EFO_0009597 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNGAFLAFERRHEFM | 216 | Q9NPC4 | |
| GFTKRLFRELMGDHV | 306 | Q9H568 | |
| DSEVGKAGHIMRRFF | 1876 | Q9UIF9 | |
| FKSDHGRRFTMGERI | 261 | O14503 | |
| MAMRLILFFGALFGH | 1 | P48052 | |
| GFIKCVDRDVRMFFH | 361 | O75534 | |
| KDHAVFTRRGEDLFM | 246 | P31689 | |
| LMFDKTTNRHRGFGF | 141 | Q96DH6 | |
| KMRHDVGEFPVLFFG | 1786 | Q96L73 | |
| PVGRAHFMDFLGKEF | 311 | O94810 | |
| FKDLHFKMFDVGGQR | 191 | P63096 | |
| FKDLHFRMFDVGGQR | 191 | A8MTJ3 | |
| MIFGKAHEFIELIFG | 496 | Q8TD91 | |
| ELDVHLRRMESGFGF | 776 | Q86UL8 | |
| MGFLHGIFERLKQFL | 236 | Q9UI26 | |
| FGGMRLLRRADFHVG | 1291 | Q10570 | |
| QFHDLMELFRIGGKS | 61 | P62714 | |
| QFHDLMELFRIGGKS | 61 | P67775 | |
| FHMFDVGGQRDERRK | 206 | P38405 | |
| LFGSEFFMGRLVKRI | 551 | Q3MJ16 | |
| IGRFIAMALFHGKFI | 641 | Q96J02 | |
| LKRVFGMFAHTEDRE | 326 | O43614 | |
| ADKRIHFGVGVMLGF | 466 | Q9NXS3 | |
| GERFMKFSRVARGCH | 796 | Q9BX69 | |
| IMILFRFIHGKDVFE | 436 | Q13619 | |
| HLRLKMYEFAGRLVG | 546 | O15033 | |
| FIEMFFGRHIGLDEE | 2396 | Q99698 | |
| FEGHFLKVLFDRMGR | 631 | Q5W0V3 | |
| HAMARKRGEGGRFFS | 306 | P23511 | |
| FRVERGADGKMFLHY | 41 | O75343 | |
| LRHAFREMFSVGGLF | 181 | Q96K19 | |
| GHRMNIDRALKFFLE | 2146 | Q9Y566 | |
| FQKRHMEGAFLFAVL | 181 | Q9BVK2 | |
| RMLGGFKHKNFRTRE | 131 | Q7Z460 | |
| GTLRKHMFFRDRYGT | 151 | A6NDS4 | |
| GTLRKHMFFRDRYGT | 151 | P0C7X1 | |
| RFIGRFIAMALYHGK | 606 | O00308 | |
| FGGREHVLMFAKLAL | 411 | Q9BSA9 | |
| KDGRFHLRVFMEAVL | 106 | P60852 | |
| DFLKSHIKRGFREGF | 196 | Q5T0L3 | |
| KVRFLMGGRHGEFKF | 786 | Q15413 | |
| GRFIAMALFHGKFID | 661 | Q9H0M0 | |
| LGEFHLRMKGLAGFA | 206 | Q6ZS17 | |
| GTLRKHMFFRDRYGT | 151 | Q6DHY5 | |
| IRKGRERHLFLFEMS | 1501 | O75962 | |
| KEGRRHGFGQLMFAD | 21 | Q8NDC4 |